This indefinite delivery contract (IDC) awarded by the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 20 to Roche Diagnostics Corporation provides reagents, consumables, and supplies for whole blood glucose testing at VA medical facilities in VISN 20. The $534,276 single-award contract has a period of performance from March 15, 2025, through March 14, 2030.
The contract aims to procure point-of-care whole blood glucose testing devices, interfaceable middleware, supplies, reagents, and consumables required to perform the necessary medical testing. The original solicitation was issued under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC code 6640 for Laboratory Equipment and Supplies. The contract has no specific set-aside designation. Roche Diagnostics has previously received awards from the VA, DoD, HHS, USDA, and other federal agencies to provide critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services through its GSA Schedule contracts and other IDCs and BPAs.
Generated 3/13/25, 10:13 AM